Immune checkpoints in a genetically engineered mouse model of spontaneous autoimmune uveitis
The Journal of Immunology · 2026
DOI: 10.1093/jimmun/vkaf334 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Mianmian Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States. Hauptthemen laut MEDLINE: Uveitis, Autoimmune Diseases, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIDCR NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Engineered mutant AireGW/+Lyn−/− C57BL/6 mice are a model of spontaneous autoimmunity in which 50% of mice develop highly destructive uveitis due to compromised central and peripheral T cell tolerance. The key retinal autoantigen in these mice is interphotoreceptor retinoid-binding protein (IRBP). The CD4+ T cells recognizing the dominant epitope of IRBP, called P2, from eye-draining lymph nodes of mice with or without uveitis and from the retinas of mice with uveitis, were characterized by single-cell RNA sequencing (scRNA-seq) and flow cytometry. Mice with uveitis had autoantigen-specific T cells in the eye-draining lymph node and in the retinas, exhibiting a range of activation states and a Th1 polarization, along with a small fraction of Tregs. Mice without uveitis had low numbers of P2-specific T cells in the eye-draining lymph nodes, and in most mice a substantial proportion of them were FoxP3+ Tregs. Transient depletion of Tregs by treatment of heathy AireGW/+Lyn−/− Foxp3DTR+/Y mice with diphtheria toxin resulted in rapid expansion of P2-specific CD4+ T cells in the eye-draining LN, and some of the Treg depleted mice went on to develop uveitis. Thus, development of inflammation in the retina was limited by a checkpoint in the eye-draining lymph nodes involving Tregs, and also apparently by an additional peripheral tolerogenic mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.
- Departments of Otolaryngology and Microbiology & Immunology, Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, S…
- Diabetes Center, University of California, San Francisco, San Francisco, CA, United States.
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States.
- Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD, United States.
- Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
ORCID-Profile: Mianmian Yin, Rachel R Caspi
Förderung
- NIH HHS
- NIDCR NIH HHS
- NIAID NIH HHS
- NIH
Zitieren
APA
Yin, M., Hiam-Galvez, K. J., Proekt, I., Chan, J., Hu, Y., Lowell, C. A., Caspi, R. R., Spitzer, M. H., Anderson, M. S., & DeFranco, A. L. (2026). Immune checkpoints in a genetically engineered mouse model of spontaneous autoimmune uveitis. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf334
Vancouver
Yin M, Hiam-Galvez KJ, Proekt I, Chan J, Hu Y, Lowell CA, et al. Immune checkpoints in a genetically engineered mouse model of spontaneous autoimmune uveitis. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkaf334
BibTeX
@article{Yin2026,
author = {Yin, Mianmian and Hiam-Galvez, Kamir J and Proekt, Irina and Chan, Jackie and Hu, Yongmei and Lowell, Clifford A and Caspi, Rachel R and Spitzer, Matthew H and Anderson, Mark S and DeFranco, Anthony L},
title = {Immune checkpoints in a genetically engineered mouse model of spontaneous autoimmune uveitis},
journal = {The Journal of Immunology},
year = {2026},
doi = {10.1093/jimmun/vkaf334}
}
EUVIMED